FDA Clearance and Electromagnetic Devices

What this means

In U.S. device law, clearance and approval are not interchangeable. A 510(k) clearance means FDA reviewed a premarket notification and found the new device substantially equivalent to a legally marketed predicate for a stated intended use. That is a comparative decision. It is not a blanket finding that every later advertisement is true.

Premarket approval, or PMA, is a different path. FDA describes PMA as the more stringent review used for many high-risk Class III devices, based on valid scientific evidence that the device is safe and effective for its intended use. Some electromagnetic products have used PMA historically. Others use 510(k). The pathway on a brochure does not tell you the clinic’s marketing claim is the labeled use.

Wellness products sit in a third conversation. FDA’s general-wellness policy discusses low-risk products intended only for general wellness, not to diagnose, cure, mitigate, prevent, or treat a disease. A PEMF mat sold for relaxation is not automatically the same regulatory object as a prescription bone-growth stimulator. The intended use on the label is the useful fact.

When a longevity clinic says a device is “FDA cleared,” ask cleared for what. The indication-for-use statement is short and specific. Uses that are not on that statement are not the cleared indication, even if the hardware looks similar to a device you read about in an orthopedic pamphlet.

What the evidence shows

FDA’s 510(k) page states that a submitter must show the device is as safe and effective as a predicate—that is, substantially equivalent. Clinical data may be included, but they are not required for every 510(k). A clearance letter is not a systematic review of every condition listed on a wellness website.

Non-invasive bone-growth stimulators are a concrete example. FDA has regulated these as prescription devices intended to promote osteogenesis as an adjunct to fracture fixation or spinal fusion, or as treatment for established nonunions or failed fusions. That labeled orthopedic use is not a license to market the same physics for anti-aging, detox, or mood.

In 2026, FDA published a final order reclassifying certain non-invasive bone-growth stimulators from Class III to Class II with special controls, allowing a 510(k) instead of a new PMA for that device type. Reclassification changes the marketing pathway. It does not turn a spa mat into a prescription stimulator, and it does not validate unrelated wellness claims.

Independent clinical evidence is device-specific and indication-specific. Cochrane’s review of electromagnetic field stimulation for delayed union or non-union of long bones found a possible benefit but called the evidence inconclusive and insufficient to guide practice. That uncertainty applies even more to consumer devices that were never the studied hardware.

Common myths

A common myth is that “FDA cleared” means “FDA approved to treat this disease.” Clearance is not approval, and neither word expands the labeled indication. A device can be legally on the market for one use while a clinic sells another use that FDA never reviewed for that product.

Another myth is that all electromagnetic products are the same because they involve a magnetic field. Field strength, waveform, coil geometry, treatment site, dose, and whether the product is a prescription device all change what was studied. A refrigerator magnet, a wellness mat, a fracture stimulator, and a TMS coil are not one therapy.

A third myth is that general-wellness language is a loophole that still implies medical effectiveness. FDA’s wellness policy is about low-risk products and non-disease claims. It is not a finding that the product treats osteoarthritis, depression, or nonunion. Disease claims need a matching intended use.

A fourth myth is that a higher price or a clinic setting upgrades the regulatory status. Place of service does not change the label. If staff cannot show the indication and only describe “cellular energy” or “optimization,” you are hearing marketing, not the cleared use.

How clinics use it

Some orthopedic and spine practices prescribe a labeled bone-growth stimulator after a defined diagnosis such as established nonunion or as an adjunct to fusion. That path usually includes imaging, a surgeon or treating clinician, and a device chosen for that indication. It is not a drop-in wellness add-on.

Longevity and recovery clinics more often offer shared PEMF beds, chairs, or mats as cash-pay sessions. Those offerings may be marketed for soreness, sleep, or general recovery. The session can feel relaxing. That feeling is not evidence that the device matches a fracture-stimulator indication or a psychiatric indication.

You may also see stacked protocols: PEMF plus red light, compression, or supplements in one membership. Stacking does not create a new FDA review. Each device still has its own intended use, and each claim still needs its own evidence. Ask which outcome will be measured besides “you will feel it.”

Licensed clinicians can still discuss off-label or unproven adjuncts, but they should name the uncertainty, screen for implants and pregnancy, and not replace indicated fracture care, infection workup, or mental-health evaluation. If the only person explaining the device is a salesperson, that is not a medical indication review.

Practical takeaway

Ask for three documents or facts before you book a package: the device name, the 510(k) or PMA number if the clinic claims FDA status, and the exact indication-for-use statement. Compare that sentence with the website headline. If they do not match, the headline is not the cleared use.

Treat wellness PEMF as optional comfort care unless a licensed clinician has tied a prescription device to a labeled orthopedic indication and a follow-up plan. Do not delay imaging for a fracture that is not healing, neurologic change, unexplained weight loss, or chest pain in order to complete a mat series.

Screen safety the way you would for any energy device. People with pacemakers, implanted defibrillators, some other electronic implants, or pregnancy should ask the prescribing clinician and check the specific product labeling. “It is only a magnet” is not a safety assessment.

Keep the decision small and reversible. Pay for a defined trial, pick one symptom or function to track, and set a stop date. If the clinic cannot explain clearance versus approval, or cannot separate the labeled indication from wellness copy, choose licensed evaluation for the actual problem instead of another device package.